This section presents statistics and data on granted projects, broken down by call year, countries, funders, gender and type of cancer. Here you can explore in more detail where we fund research.
Overview of the call on “Translational research on cancer epigenetics”
Statistical analysis of the call on “Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy”
Overview of the co-funded call on "Next generation cancer immunotherapy: targeting the tumour microenvironment"
Overview of the call on "Translational research on Rare Cancers"
Overview of the call on “Minimally and non-invasive methods for early detection and/or progression of cancer”
Overview of the call on “Immunology and immunotherapy of cancer: strengthening the translational aspects”
Overview of the EC cofunded call on “Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy”
Subscribe to our Newsletter You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter.
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 964264.
Legal Notice | Privacy Policy